A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies

A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies

<b>Background/Objectives:</b> Trastuzumab is an effective therapeutic intervention for treating HER2-positive breast cancers. The cost-effectiveness, global demand, and patent expiration of trastuzumab have led to the inflow of its biosimilars in the global market. With the rise of biosi...

Full description

Saved in:
Bibliographic Details
Main Authors: Pooja Bharali, Subhash Chand, Harish Chander
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
trastuzumab
biosimilars
anti-proliferation assay
biological activity
Online Access:https://www.mdpi.com/2227-9059/13/1/23
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items